We propose to investigate the mechanisms of gene induction by ionizing radiation that may have novel applications in radiotherapy. Data from our laboratory suggest that genetic constructs which are relatively specific for radiation-induction can be engineered to amplify gene transcription. We will construct recombinant DNA plasmids encoding cytotoxic proteins which will be transcribed following exposure to x-rays. We will insert x-ray inducible DNA sequences obtained from deletion analysis of the c-jun promoter, upstream of the transcription start site of a toxin gene. The specificity of toxin induction will be accomplished by constructing a plasmid encoding a radiation-activated hybrid transcription factor consisting of a yeast DNA-binding peptide (Gal4) and a mammalian transcriptional activator peptide (Jun). Following radiation-activation of the hybrid transcription factor Gal-Jun, the activated protein will bind the yeast GAL4 promoter on a second plasmid encoding a cytotoxic and/or radiosensitizing protein. We will investigate whether our proposed strategy can produce a biologically active protein with cell killing or radiosensitizing properties. We will select tumor necrosis factor alpha for our initial studies because this protein has been demonstrated to be a cytotoxin and/or a radiosensitizer in tumor cells studied in our laboratory. Our studies will characterize a prototype radiation-inducible plasmid encoding a cytotoxic protein and provide a foundation for the development of a genetic radiotherapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041068-08
Application #
2090343
Study Section
Radiation Study Section (RAD)
Project Start
1985-05-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Chicago
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Chmura, S J; Dolan, M E; Cha, A et al. (2000) In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res 6:737-42
Fortunato, J E; Mauceri, H J; Kocharyan, H et al. (2000) Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia. J Surg Res 89:155-62
Advani, S J; Chung, S M; Yan, S Y et al. (1999) Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res 59:2055-8
Gorski, D H; Beckett, M A; Jaskowiak, N T et al. (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59:3374-8
Seetharam, S; Staba, M J; Schumm, L P et al. (1999) Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation. Int J Oncol 15:769-73
Epperly, M; Bray, J; Kraeger, S et al. (1998) Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 5:196-208
Chung, T D; Mauceri, H J; Hallahan, D E et al. (1998) Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer. Cancer Gene Ther 5:344-9
Staba, M J; Mauceri, H J; Kufe, D W et al. (1998) Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Ther 5:293-300
Hanna, N N; Mauceri, H J; Wayne, J D et al. (1997) Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res 57:4205-9
Chmura, S J; Nodzenski, E; Beckett, M A et al. (1997) Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res 57:1270-5

Showing the most recent 10 out of 57 publications